Skip to content
October 25, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Breast Cancer Prevention and Lifestyle
  • A Triumph Over Blindness: Tunisia Officially Eliminates Trachoma as a Public Health Problem
  • Breast Cancer Prevention and Lifestyle

A Triumph Over Blindness: Tunisia Officially Eliminates Trachoma as a Public Health Problem

Iffa Jayyana May 21, 2026 7 minutes read
0
a-triumph-over-blindness-tunisia-officially-eliminates-trachoma-as-a-public-health-problem

In a landmark achievement for global public health, the World Health Organization (WHO) has officially validated Tunisia as having successfully eliminated trachoma as a public health problem. This milestone marks the culmination of decades of rigorous, sustained, and coordinated national effort. By conquering this condition—the world’s leading infectious cause of blindness—Tunisia has demonstrated that even the most persistent neglected tropical diseases (NTDs) can be eradicated through political will, robust primary healthcare systems, and community engagement.

The Magnitude of the Achievement

For much of the 20th century, trachoma was a formidable health crisis in Tunisia, particularly in the country’s southern regions. At its peak, the disease—caused by the bacterium Chlamydia trachomatis—affected at least 50% of the population. The chronic infection, which spreads through contact with contaminated surfaces, flies, and close personal proximity, often leads to irreversible scarring of the eyelids. If left untreated, the eyelashes turn inward, scraping the eyeball and causing agonizing pain and permanent blindness.

The WHO’s validation signifies that Tunisia has met the stringent international criteria for elimination. This includes reducing the prevalence of trachomatous trichiasis (the advanced, blinding stage of the disease) to less than 0.2% in adults aged 15 and older, and ensuring the prevalence of trachomatous inflammation-follicular (the active form of the disease) in children aged 1–9 remains below 5% in every formerly endemic district. Furthermore, the country has established a sustainable surveillance system to identify and manage any potential future cases, ensuring the disease does not return.

Chronology: A Multi-Decade Strategy

The road to elimination was neither swift nor easy. It required a generational commitment to transforming the country’s health and sanitation infrastructure.

Early to Mid-20th Century: The Endemic Era

During the early and mid-1900s, trachoma was a widespread endemic threat. The socio-economic conditions of the time—characterized by limited access to clean water and inadequate sanitation—provided a fertile environment for the transmission of the Chlamydia trachomatis bacterium. The disease disproportionately targeted the most vulnerable, particularly those living in impoverished rural settings.

The Implementation of the SAFE Strategy

Tunisia’s success was anchored in the wholesale adoption of the WHO-recommended "SAFE" strategy. This multi-faceted approach served as the blueprint for the country’s intervention:

  • S (Surgery): Targeted interventions to correct the inward-turning eyelashes in advanced cases, preventing permanent vision loss.
  • A (Antibiotics): Mass drug administration and individual treatments to clear the bacterial infection from the population.
  • F (Facial Cleanliness): Extensive public health campaigns aimed at reducing transmission through improved personal hygiene and community-led health education.
  • E (Environmental Improvement): A critical pillar of the strategy, involving massive investments in water, sanitation, and hygiene (WASH) infrastructure to break the chain of transmission.

Modernization and Integration

Beyond the SAFE strategy, the Ministry of Health integrated eye care directly into primary health services and school health programs. This move ensured that screening and treatment were not siloed, but were instead a routine part of the Tunisian healthcare experience. By working closely with local communities, the government fostered a culture of prevention, transforming the fight against trachoma into a collective national mission.

Supporting Data and Global Context

Tunisia is now the 31st country globally to be validated by the WHO for the elimination of trachoma, and it is the 14th country in the WHO Eastern Mediterranean Region to eliminate at least one neglected tropical disease.

The Global Landscape

The global effort to eliminate trachoma gained significant momentum in 1996 with the launch of the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020). This network brought together governments, international NGOs, and academic institutions to standardize data collection and intervention strategies. Despite the initial 2020 target date, the goal remains a top priority under the WHO’s "Road map for neglected tropical diseases 2021–2030."

Tunisia joins an esteemed list of nations that have successfully navigated the challenges of eliminating trachoma, including Algeria, Morocco, Oman, Saudi Arabia, and Egypt. This list underscores a broader trend: as countries improve their water and sanitation infrastructure, they become increasingly resilient against the spread of water-borne and contact-based pathogens.

Official Responses and Reflections

The validation has drawn praise from the highest echelons of global health leadership.

"I congratulate Tunisia on this historic public health achievement," stated Dr. Tedros Adhanom Ghebreyesus, WHO Director-General. "Eliminating trachoma shows what long-term political commitment, strong primary health care, and teamwork can do. Tunisia has proven that even the world’s leading infectious cause of blindness can be overcome."

Dr. Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean, echoed these sentiments, noting that the victory is a reflection of consistent national focus. "This is a major achievement that reflects sustained and consistent national commitment over many years and shows what is possible when a country remains focused on addressing preventable causes of blindness," she said.

From the perspective of the Tunisian government, the victory is seen as a validation of the country’s broader commitment to health equity. Dr. Mustapha Ferjani, the Minister of Health of Tunisia, highlighted the role of the workforce: "This milestone is the result of decades of coordinated national efforts, with the dedication of generations of health-care professionals, local communities who worked tirelessly to expand access to care, strengthen prevention, and improve eye health across the country."

Dr. Ahmed Zouiten, Acting WHO Representative in Tunisia, emphasized the importance of science-led policy. "This milestone stands as a strong demonstration of how science, evidence-based programming, and coordinated technical support can overcome neglected tropical diseases every time and everywhere," he remarked.

Implications for Future Public Health

The elimination of trachoma in Tunisia is not merely a historical milestone; it serves as a functional template for other nations currently battling NTDs.

The Power of Surveillance

A crucial component of the current success is the establishment of a robust post-validation surveillance system. This ensures that if a case of trachoma is detected, it can be treated before it gains a foothold in the community. By training health professionals and maintaining a high level of vigilance, Tunisia is ensuring that the gains of the past decades are not lost.

Economic and Social Impact

Neglected tropical diseases are, by definition, diseases of poverty. They create a cycle of disadvantage: individuals lose their sight, leading to a loss of productivity, which in turn deepens the poverty of the community. By eliminating trachoma, Tunisia has removed a significant barrier to economic growth and personal well-being for thousands of citizens. This victory will have long-term positive ripple effects on education, employment, and social inclusion.

A Catalyst for Other Targets

Tunisia’s achievement acts as a catalyst for the country’s work toward the health-related Sustainable Development Goals (SDGs). Having successfully tackled trachoma, the Tunisian health system is better positioned to address other chronic and infectious health challenges. The infrastructure built—the community health networks, the sanitation improvements, and the diagnostic capabilities—now serves as a foundation for future public health successes.

Conclusion

Tunisia’s journey from high disease prevalence to total elimination is a testament to the power of a comprehensive, government-led, and community-supported public health strategy. It sends a powerful message to the international community: with the right tools, the right partnerships, and the necessary, long-term political commitment, the eradication of neglected tropical diseases is not just an aspiration—it is an achievable reality. As Tunisia celebrates this historic victory, it stands as a beacon of progress in the global movement toward universal health coverage and a world free from the threat of preventable blindness.

About the Author

Iffa Jayyana

Author

View All Posts

Post navigation

Previous: The New Frontier of Oncology: Key Breakthroughs from the 119th AACR Annual Meeting
Next: The Precision Revolution: How Flexible Instruments are Redefining Minimally Invasive Surgery

Related Stories

strengthening-the-global-health-architecture-a-deep-dive-into-the-belgium-who-strategic-partnership
  • Breast Cancer Prevention and Lifestyle

Strengthening the Global Health Architecture: A Deep Dive into the Belgium-WHO Strategic Partnership

Pevita Pearce October 25, 2026
a-new-era-of-health-sovereignty-who-and-au-forge-strategic-alliance-to-reshape-african-healthcare
  • Breast Cancer Prevention and Lifestyle

A New Era of Health Sovereignty: WHO and AU Forge Strategic Alliance to Reshape African Healthcare

Raul Delapena Setiawan October 25, 2026
a-fractured-partnership-the-who-responds-to-the-u-s-withdrawal
  • Breast Cancer Prevention and Lifestyle

A Fractured Partnership: The WHO Responds to the U.S. Withdrawal

Laily UPN October 24, 2026

Recent Posts

  • A New Trojan Horse: Mount Sinai Scientists Engineer CAR T-Cells to Dismantle Cancer’s Defenses, Offering Hope for Metastatic Tumors
  • Personalized Cancer Vaccine Shows Promise, But Data Leak Dampens Initial Enthusiasm
  • Empowering Action: Your Comprehensive Guide to Planning a Meaningful Breast Cancer Awareness Month
  • Bridging the Gap: How Taylarr Lopez is Redefining Public Health Communications for Equitable Care
  • Strengthening the Global Health Architecture: A Deep Dive into the Belgium-WHO Strategic Partnership

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

a-new-trojan-horse-mount-sinai-scientists-engineer-car-t-cells-to-dismantle-cancers-defenses-offering-hope-for-metastatic-tumors
  • Medical Research and Clinical Trials

A New Trojan Horse: Mount Sinai Scientists Engineer CAR T-Cells to Dismantle Cancer’s Defenses, Offering Hope for Metastatic Tumors

Layla Zulfa October 25, 2026
personalized-cancer-vaccine-shows-promise-but-data-leak-dampens-initial-enthusiasm
  • Medical Research and Clinical Trials

Personalized Cancer Vaccine Shows Promise, But Data Leak Dampens Initial Enthusiasm

Azzam Bilal Chamdy October 25, 2026
empowering-action-your-comprehensive-guide-to-planning-a-meaningful-breast-cancer-awareness-month
  • Patient Advocacy and Support

Empowering Action: Your Comprehensive Guide to Planning a Meaningful Breast Cancer Awareness Month

Nana October 25, 2026
bridging-the-gap-how-taylarr-lopez-is-redefining-public-health-communications-for-equitable-care
  • Patient Advocacy and Support

Bridging the Gap: How Taylarr Lopez is Redefining Public Health Communications for Equitable Care

Raul Delapena Setiawan October 25, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.